Alzheimer's disease as proteolytic disorders: Anabolism and catabolism of β-amyloid

Neurobiology of Aging

Volumn 19, Issue SUPPL. 1, 1998, Pages

  Saido, T C ^a,b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Amyloid; Alzheimer's disease; Aminopeptidase; Catabolism

Indexed keywords

AMINOPEPTIDASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GLUTAMYL AMINOPEPTIDASE;

ALZHEIMER DISEASE; CATABOLISM; CONFERENCE PAPER; GENE MUTATION; HUMAN; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMINOPEPTIDASES; AMYLOID BETA-PROTEIN; BRAIN CHEMISTRY; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 0031969223     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00033-5     Document Type: Conference Paper

References (34)

1. Barret A. J., Slvesen G. Proteinase Inhibitors. 1986;Elsevier, Amsterdam.
2. Borchelt D. R., Thinakaran G., Eckman C. B., Lee M. K., Davenport F., Ratovitsky T., Prada C.-M., Kim G., Seekins S., Yager D., Slunt H. H., Wang R., Seeger M., Levey A. I., Gandy S. E., Copeland N. G., Jenkins N. A., Price D. L., Younkin S. G., Sisodia S. S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
3. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St. George Hyslop P., Selkoe D. J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3:1997;67-72.
4. Duff K., Eckman C., Zehr C., Yu X., Prada C.-M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M. N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
5. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
6. Gravina S. A., Ho L., Eckman C. B., Long K. E., Otvos L. Jr, Younkin L. H., Suzuki N., Younkin S. G. Amyloid β protein (Aβ) in Alzheimer's disease brain. J. Biol. Chem. 270:1995;7013-7016.
7. Haass C., Selkoe D. J. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-protein. Cell. 75:1993;1039-1042.
8. Harigaya Y., Eckman C. B., Prada C.-M., Saido T. C., Younkin S. G. Biochemical analysis of amyloid β protein with amino-terminal pyroglutamate 3 in Alzheimer's disease brains. Soc. Neurosci. 26:1996;1170.
9. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
10. Iribar C., Esteban M. J., Martinez J. M., Peinado J. M. Decrease in cytoplasmic aspartyl-aminopeptidase but not in alanyl-aminopeptidase in the frontal cortex of the aged rat. Brain Res. 687:1995;211-2113.
11. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals evidence that an initially deposited Aβ species is Aβ42(43) . Neuron. 13:1994;45-53.
12. Iwatsubo T., Saido T. C., Mann D. M. A., Lee V. M.-Y., Trojanowski J. Q. Full-length Aβ(1-42(43)) as well as amino-terminally modified and truncated Aβ42(43) deposit in diffuse plaques. Am. J. Pathol. 149:1996;1823-1830.
13. Kuda T., Shoji M., Arai H., Kawashima S., Saido T. C. Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease A potential biochemical marker . Biochem. Biophys. Res. Commun. 231:1997;526-530.
14. Lemere, C. A.; Lopera, F.; Kosik, K. S.; Lendon, C. L.; Ossa, J.; Saido, T. C.; Yamaguchi, H.; Ruiz, A.; Martinez, A.; Madrigal, L.; Hincapie, L.; Arango, L., J. C.; Anthony, D. C.; Koo, E. H.; Goate, A. M.; Selkoe, D. J.; Arango V., J. C. The E280A Presenilin 1 mutation leads to a distinct Alzheimer's disease phenotype: Increased Aβ42 deposition and severe cerebellar pathology. Nature Med. 2:1146-1150; 1996.
15. Mann D. M. A., Esiri M. M. The site of the earliest lesions of Alzheimer's disease. N. Engl. J. Med. 318:1988;789-790.
16. Mann D. M. A., Iwatsubo T., Cairns N. J., Lantos P. L., Nochlin D., Sumi S. M., Bird T. D., Poorkaj P., Hardy J., Hutton M., Prihar G., Crook R., Rossor M. N., Haltia M. Amyloid β protein (Aβ) deposition in chromosome 14-linked Alzheimer's disease Predominance of Aβ42(43) . Ann. Neurol. 40:1996;149-156.
17. Mann D. M. A., Iwatsubo T., Ihara Y., Cairns N. J., Lantos P. L., Bogdanovic N., Lannfelt L., Winbland B., Maat-Schieman M. L., Rossor M. N. Predominant deposition of amyloid-β42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am. J. Pathol. 148:1996;1257-1266.
18. McDonald, J. K.; Barret, A. J. Mammalian Proteases: A Glossary and Bibliography Vol. 1: Endopeptidases. London: Academic Press; 1980.
19. McDonald, J. K.; Barret, A. J. Mammalian Proteases: A Glossary and Bibliography Vol. 2: Exopeptidases. London: Academic Press; 1986.
20. Oyama F., Cairns N. J., Shimada H., Oyama R., Titani K., Ihara Y. Down's syndrome up-regulation of β-amyloid protein precursor and τ mRNAs and their defective coordination . J. Neurochem. 62:1994;1062-1066.
21. Pike C. J., Overman M. J., Cotman C. W. Amino-terminal deletions enhance aggregation of β-amyloid peptides in vitro. J. Biol. Chem. 270:1995;23895-23898.
22. Ramirez M., Sanchez B., Arechaga G., Lardelli P., Garcia S., Ozaita A., de Gandarias J. M. Daily rhythm of aspartate aminopeptidase activity in the retina, pineal gland and occipital cortex of the rat. Neuroendocrinol. 56:1992;926-929.
23. Rogers J. Inflammation as a pathogenic mechanism in Alzheimer's disease. Arzneimittel-Forschung/Drug Res. 45:1995;439-442.
24. Russo C., Saido T. C., DeBusk L. M., Tabaton M., Gambetti P., Teller J. K. Heterogeneity of water-soluble amyloid β-peptide in Alzheimer's disease and Down's syndrome brains. FEBS Lett. 409:1997;411-416.
25. N3(pE), in senile plaques. Neuron. 14:1995;457-466.
26. Saido T. C. Aminopeptidase hypothesis for β-amyloid (Aβ)catabolism in brain. Soc. Neurosci. 26:1996;1660.
27. Saido T. C., Yamao-Harigaya W., Iwatsubo T., Kawashima S. Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain. Neurosci. Lett. 215:1996;173-176.
28. Saido T. C., Yokota M., Tani E., Kawashima S. Post-secretory catabolism of β-amyloid in brain. Iqbal K., Winblad B., Nishimura T., Takeda M., Wisniewski H.M. Alzheimer's Disease Biology, Diagnosis and Therapeutics . 1997;339-348 John Wiley & Sons Ltd, Chichester.
29. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:1996;864-870.
30. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., Cai X.-D., McKay D. M., Tintner R., Frangione B., Younkin S. G. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science. 258:1992;126-129.
31. Sisodia S. S., Price D. L. Role of the β-amyloid in Alzheimer's disease. FASEB J. 9:1995;366-370.
32. 717) mutants. Science. 264:1994;1336-1340.
33. Tomita, T.; Maruyama, K.; Saido, T. C.; Kume, H.; Shinozaki, K.; Tokuhiro, S.; Capell, A.; Walter, J.; Gruenberg, J.; Haass, C.; Iwatsubo, T.; Obata, K. The presenilin 2 mutation (N141I) linked to familial Alzheimer's disease (Volga German families) increases the secretion of amyloid β-protein ending at Aβ42(43). Proc. Natl. Acad. Sci. USA 94:2025-; 1997.
34. White L., Petrovitch H., Ross W., Masaki K. H., Abbott R. D., Teng E. L., Rodriguez B. L., Blanchette P. L., Havlik R. J., Wergowske G., Chiu D., Foley D. J., Murdaugh C., Curb D. J. Prevalence of dementia in older Japanese-American Men in Hawaii, the Honolulu-Asia aging study. J. Am. Med. Assoc. 276:1996;955-960.